A levodopa-carbidopa intestinal gel (LCIG) works better than standard oral levodopa-carbidopa in reducing "off" time in patients with advanced Parkinson's disease.

NEW ORLEANS, April 17, 2012 /PRNewswire-USNewswire/ -- A levodopa-carbidopa intestinal gel (LCIG) works better than standard oral levodopa-carbidopa in reducing "off" time in patients

ABBOTT PARK, Ill., April 17, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) announced today the results from a Phase 3 trial evaluating the company's investigational compound for advanced Parkinson's

WALTHAM, Mass., May 12 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that while levodopa remains the gold standard for Parkinson's disease treatment, physicians say they will increasingly use other agents to delay the need for levodopa.

SANTA ANA, Calif., July 28 /PRNewswire/ -- Alar Corporation is proud to announce the launch of its brand new website, http://www.alarcorporation.com.The new site provides users with a comprehensive overview of the company and features a compelling series of homepage videos and an interactive Risk Assessment Tool that guides users through a short list of questions to learn whether their company is at risk for workplace dysfunction such as theft, drugs, violence, turnover, or unknowingly hiring an illegal workforce.